Neonatal Toxoplasma gondii IgM FEIA
In a 5 year study in Brazil over 285 000 neonates were screened with Labsystems Diagnostics’ Neonatal Toxoplasma gondii IgM FEIA and the prevalence was found to be 1/1867.
Fluorometric enzyme immunoassay for the determination of IgM antibodies to Toxoplasma gondii from dried blood spots. This is the first Neonatal Toxoplasma screening test in the world.
Labsystems Diagnostics’ Neonatal Toxoplasma gondii IgM FEIA is a fluorometric enzyme immunoassay intended for the determination of IgM-class antibodies to Toxoplasma gondii in blood samples dried on filter paper. The test is intended as a primary method for screening newborns for congenital toxoplasmosis (CT).
Benefits
First Neonatal Toxoplasma screening test in the world
Quantitative results
Clinically proven performance
High sensitive µ-capture test
Neonatal Toxoplasma gondii IgM FEIA, 5 strip plates (12×8), 480 wells 61 99 802
Based on 0 reviews
Only logged in customers who have purchased this product may leave a review.
There are no reviews yet.